End Stage Renal Disease on Dialysis
66
14
19
25
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.5%
1 terminated out of 66 trials
96.2%
+9.7% vs benchmark
11%
7 trials in Phase 3/4
4%
1 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (66)
Diuretic Use in Hemodialysis Patients With Residual Renal Function
Interdialytic Peritoneal UltraFiltration in HemoDialysis Patients
MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence
VR Study Virtual Reality for Patients During Arteriovenous Fistula Surgery
A Pilot Trial of Chinese Medicine for Patients With Dialytic Hypotension
DIALYSIS-TIR Study
Comparing Surgical and Endovascular Arteriovenous Fistula Creation
The Home Blood Pressure (BP) Trial
Intradialytic Kinetics of Cardiac Biomarkers During Hemodialysis and Hemodiafiltration
Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD
Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular Disease and Dialysis Access
Assessment of D-dimer and CRP for Cardiovascular Risk Prediction in Hemodialysis Patients
Efficacy of pHA130 Hemoadsorption for 4 Hours (p4H Study)
Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients
Independent Effects of Visceral Adipose Volume and Density on Patient Survival in Peritoneal Dialysis
Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
First Evaluation of the Moda-Flx Hemodialysis System™ in Real World Clinical Settings
Effects of pHA Hemoperfusion Plus Hemodialysis on Protein-Bound Uremic Toxins
Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis)